Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Neulasta

Neulasta

(pegfilgrastim) injection

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 7 Apr, 2022
Vitalii Mazuryk profile picture
Vitalii Mazuryk
edited on 7 Apr, 2022
Edits made to:
Description (+25 characters)
Article (+289 characters)
Topic thumbnail

Neulasta

(pegfilgrastim) injection

Article

Neulasta® (pegfilgrastim) is a prescription medicine used to help reduce the chance of infection due to a low white blood cell count, in people with certain types of cancer (non‑myeloid), who receive anti-cancer medicines (chemotherapy) that can cause fever and low white blood cell count.

"Edit from table cell"
Vitalii Mazuryk profile picture
Vitalii Mazuryk
edited on 7 Apr, 2022
Edits made to:
Infobox (+2 properties)
Infobox
Industry
Pharmaceutical industry
Pharmaceutical industry
Product parent company
Amgen
Amgen
"Created via: Web app"
Vitalii Mazuryk profile picture
Vitalii Mazuryk
created this topic on 7 Apr, 2022
Edits made to:
Infobox (+2 properties)
Topic thumbnail

 Neulasta

(pegfilgrastim) injection

Infobox
Is a
Product
Product
Website
https://www.neulasta.com

Find more entities like Neulasta

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.